Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. - Wikidata - awgldk - TriplyDB

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

http://www.wikidata.org/entity/Q41995033

about

The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate Zinc oxide nanoparticles-induced epigenetic change and G2/M arrest are associated with apoptosis in human epidermal keratinocytes Aluminum doping tunes band gap energy level as well as oxidative stress-mediated cytotoxicity of ZnO nanoparticles in MCF-7 cells The role of hypoxia-inducible factor-1α in zinc oxide nanoparticle-induced nephrotoxicity in vitro and in vivo Role of surface modification in zinc oxide nanoparticles and its toxicity assessment toward human dermal fibroblast cells Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models Interactions between nanosized materials and the brain In vitro genotoxic effects of ZnO nanomaterials in human peripheral lymphocytes Effects of zinc oxide nanoparticles on Kupffer cell phagosomal motility, bacterial clearance, and liver function Enhanced inactivation of bacteria by metal-oxide nanoparticles combined with visible light irradiation.Second harmonic imaging of plants tissues and cell implosion using two-photon process in ZnO nanoparticles.Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications.Comparative toxicity of nanoparticulate CuO and ZnO to soil bacterial communities Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli Comparative evaluation of impact of Zn and ZnO nanoparticles on brine shrimp (Artemia salina) larvae: effects of particle size and solubility on toxicity.Photodynamic effects of zinc oxide nanowires in skin cancer and fibroblast.Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats.Novel ZnO:Ag nanocomposites induce significant oxidative stress in human fibroblast malignant melanoma (Ht144) cells Antibacterial and Antifungal Activity of ZnO Containing Glasses Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species.Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors ZnO Nanoparticles Treatment Induces Apoptosis by Increasing Intracellular ROS Levels in LTEP-a-2 Cells.Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction Zinc oxide nanoparticle suspensions and layer-by-layer coatings inhibit staphylococcal growth Nanosized zinc oxide induces toxicity in human lung cells.Biomedical applications of zinc oxide nanomaterials.Responses of human cells to ZnO nanoparticles: a gene transcription study.Diverse Applications of Nanomedicine.What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature.Nanomaterials in biological environment: a review of computer modelling studies.Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap.Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy.Application of new ZnO nanoformulation and Ag/Fe/ZnO nanocomposites as water-based nanofluids to consider in vitro cytotoxic effects against MCF-7 breast cancer cells.The toxicology of ion-shedding zinc oxide nanoparticles.Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231).Risk assessment of zinc oxide, a cosmetic ingredient used as a UV filter of sunscreens.Zinc-Oxide Nanoparticles Exhibit Genotoxic, Clastogenic, Cytotoxic and Actin Depolymerization Effects by Inducing Oxidative Stress Responses in Macrophages and Adult Mice.In Vitro Selective Anti-Proliferative Effect of Zinc Oxide Nanoparticles Against Co-Cultured C2C12 Myoblastoma Cancer and 3T3-L1 Normal Cells.

P2860

Q24625344-2CFB4323-4A24-4971-858F-109C1D4E20A6 Q28385186-4D98F0B3-33CE-4252-A383-8D52F696A246 Q28386787-8EAB69CE-7802-486F-A135-CC7FD6CB1380 Q28387963-FE306DA2-54DC-4279-ACB0-3E9B5B1A8736 Q28390139-BD2F2819-9405-4F4C-8964-40F0283B2B3D Q28392287-505C3F10-38F8-4993-BE83-B532EDA42505 Q28394050-A4C3FC3F-47B5-422A-B4BF-FA1AA0D0ED71 Q28394343-6BDB91E8-EB82-4353-ACD3-3DF4105CAADA Q28395653-BD9022BA-9AF3-472B-AE4C-0C56E389804C Q28397780-E3835707-15D3-4A6C-80C1-9598E7A54A61 Q33849105-704D908E-01F2-4601-B23C-846E6BDD2F89 Q34063983-CA1C6047-BF04-4E7C-A5FC-41EF1CD1E18B Q34076571-6B3F99BE-3691-4F9E-9C65-E9151EB2A214 Q34222239-619A66B3-8246-41D3-B716-B737D2598244 Q34787729-A0837062-0CB6-41E4-8C26-8733EBE89385 Q34990310-30A9F243-735D-441E-8DD9-426D321CDFAC Q34995192-C4DBC306-4131-467B-AA2E-8D0875996D5C Q35066842-5DB86D51-4B78-4DF7-9AE1-D7C725B9F6A3 Q35122763-E6D306AC-CB69-4316-92FB-3E83A5ABAC14 Q35183270-A1BF10C2-DF92-4DD6-87D9-927618FC2440 Q35731321-BF369A19-322A-4B1D-9D10-189DEB2B1C39 Q35787510-E2997D96-880C-410E-84F9-7F3D24E37C55 Q35834280-958F1024-C464-4BD2-9D22-65BDF74E9F3E Q35960272-2BBFD95A-E762-4159-A2DF-1F33773D7BB5 Q36242578-50524808-8538-49E8-A16E-4F0C5ACB7DFF Q36505641-4C86B561-7A50-40AC-86DE-C3C8DE9048C8 Q37111238-F32B2D7E-D608-4C37-AAB7-2EB43DB0E66A Q37337342-B3ABAB2D-345A-4019-81B1-61C5E73C2FFB Q37435441-0AE67E3E-949C-41C3-AD3B-6D716DD63A34 Q37728142-D3626D79-E80F-4348-BC7F-3CA7B82FFD8B Q37783303-C73359A0-9653-425C-810E-47324C2C0941 Q37820408-1D689112-1EAF-4562-A449-919D22D9E78D Q38123394-5369D397-B95A-4A1D-A25E-09C96A3FEFC6 Q38557008-CBD5FDF1-E723-4591-84A2-5948AA4B932F Q38712925-2FBCB18F-7FB1-4D23-9501-3DCFDF4C38C2 Q38768649-71FE555A-22B4-4760-80E2-1639692235C1 Q38780943-CD981979-53E7-4546-84D0-1A5F47073113 Q38783310-FB2812B2-18AA-4B38-8A9E-5EE7AE0A47E3 Q38801067-41490626-F2FE-4030-9437-A272919FEF75 Q38819831-7D92EEDC-B591-4982-BB64-0547267707DD

P2860

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

http://www.wikidata.org/entity/Q41995033

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

@en

type

label

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

@en

prefLabel

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

@en

P1433

Q41995033-5F97C79D-BA22-464E-A3B6-190F5B8867EA

P1476

Q41995033-245D4EE7-97B3-479A-A344-67AB242E1EC4

P2093

Q41995033-1C28CE11-0F35-4E09-8934-84035F45AD11

Q41995033-2B0F4916-BB5A-459C-BC53-7EB054537287

Q41995033-2BDF998A-029B-4807-AD9E-5C00EF054B62

Q41995033-850A39FF-3A39-4532-B6C2-7772573AC5BD

Q41995033-85587AC8-F9D0-4869-A6FE-232F1B21E823

Q41995033-EEF1D098-8B5A-4323-A4B5-F4CAEF302CA6

Q41995033-F57D5797-8573-48DF-8E2C-0AD85CD07ADA

Q41995033-F8FA1D0C-C763-47FD-9FBF-D772701F3288

P2860

Q41995033-0D21F2AB-6FEA-4FA6-9217-A8B831223CD2

Q41995033-158CAB28-D3BF-4D35-A532-877B52E1F189

Q41995033-3F12D5D3-0FDA-4C0F-9AA0-05A1A2A23C55

Q41995033-5C7467A7-573F-4E8E-AF07-6062FED54579

Q41995033-73C86333-E9B9-4429-AC6D-60CAA8D47E14

Q41995033-88B58940-A847-4188-BE52-B5A698B4F0F2

Q41995033-9352AB05-F7D1-40C4-8634-D6F896650578

Q41995033-95A64FF7-5557-42E3-9082-7A772C136F8E

Q41995033-97DC12BD-EA51-4CE9-8B76-5B6C45092E6F

Q41995033-9DB3D83A-6BDC-4A6E-A36A-5540536F00FE

P304

Q41995033-FA395CC1-C02A-4D81-84EC-9BB4DF936952

P31

Q41995033-E817582A-4D18-459C-B62F-0D181F9EF1FE

P356

Q41995033-9182C848-0CF9-4479-8B47-B2D4C32585DE

P433

Q41995033-D0494412-F81D-46C7-8FE1-91E086F0A079

P478

Q41995033-F9BF2B3B-3F75-45B7-BA1E-E54AB1B1080E

P577

Q41995033-513586B7-A45B-40D1-8CCC-730E59A9262C

P5875

Q41995033-605A06AF-26AC-43F0-98E3-E509916E908C

P698

Q41995033-F335C8A4-673E-4E28-B25B-BC0B978B4266

P921

Q41995033-D0F74955-BD78-48F5-86CD-D6BF82A057E3

P932

Q41995033-83C11DBC-0FA8-4718-8D92-AF9CD5023E30

P356

P1433

P1476

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

@en

P2093

Alex Punnoose

http://www.w3.org/2001/XMLSchema#string

Andrew Coombs

http://www.w3.org/2001/XMLSchema#string

Cory Hanley

http://www.w3.org/2001/XMLSchema#string

Denise Wingett

http://www.w3.org/2001/XMLSchema#string

Isaac Coombs

http://www.w3.org/2001/XMLSchema#string

Janet Layne

http://www.w3.org/2001/XMLSchema#string

K M Reddy

http://www.w3.org/2001/XMLSchema#string

Kevin Feris

http://www.w3.org/2001/XMLSchema#string

P2860

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure

The CD40 antigen and its ligand

Toxic potential of materials at the nanolevel

Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm

Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death.

Drug-targeting strategies in cancer therapy.

Signalling apoptosis: a radical approach.

Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.

Nanotechnology applications in cancer.

Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes.

P304

295103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1088/0957-4484/19/29/295103

http://www.w3.org/2001/XMLSchema#string

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230984318

http://www.w3.org/2001/XMLSchema#string

P698

18836572

http://www.w3.org/2001/XMLSchema#string

P921

P932

2558672

http://www.w3.org/2001/XMLSchema#string